Editorial: Targeting different programmed cell death processes as therapeutic modalities for thyroid cancer.
作者信息
Rajabi Sadegh
机构信息
Traditional Medicine and Materia Medica Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
出版信息
Front Endocrinol (Lausanne). 2023 Jul 27;14:1255259. doi: 10.3389/fendo.2023.1255259. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Targeting different programmed cell death processes as therapeutic modalities for thyroid cancer.社论：将不同的程序性细胞死亡过程作为甲状腺癌的治疗方式
Front Endocrinol (Lausanne). 2023 Jul 27;14:1255259. doi: 10.3389/fendo.2023.1255259. eCollection 2023.
2
PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications.PD-1 配体在甲状腺上皮性肿瘤中的表达：潜在的临床意义。
Int J Mol Sci. 2019 Mar 20;20(6):1405. doi: 10.3390/ijms20061405.
3
Carcinogenesis and therapeutic strategies in thyroid cancer.甲状腺癌的致癌作用和治疗策略。
Curr Drug Targets. 2010 Jun;11(6):716-32. doi: 10.2174/138945010791170897.
4
Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.靶向甲状腺未分化癌中的 CD47 可增强巨噬细胞对肿瘤的吞噬作用，是一种很有前途的治疗策略。
Thyroid. 2019 Jul;29(7):979-992. doi: 10.1089/thy.2018.0555. Epub 2019 May 10.
5
MicroRNA-21 regulates biological behaviors in papillary thyroid carcinoma by targeting programmed cell death 4.微小RNA-21通过靶向程序性细胞死亡蛋白4调控甲状腺乳头状癌的生物学行为。
J Surg Res. 2014 Jun 1;189(1):68-74. doi: 10.1016/j.jss.2014.02.012. Epub 2014 Feb 15.
6
Inhibition of Foxp3 in cancer cells induces apoptosis of thyroid cancer cells.抑制癌细胞中的Foxp3可诱导甲状腺癌细胞凋亡。
Mol Cell Endocrinol. 2015 Jan 5;399:228-34. doi: 10.1016/j.mce.2014.10.006. Epub 2014 Oct 12.
7
Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer.分化型甲状腺癌中的癌基因、线粒体代谢与质量控制
Korean J Intern Med. 2017 Sep;32(5):780-789. doi: 10.3904/kjim.2016.420. Epub 2017 Aug 22.
8
Signaling Pathways in Thyroid Cancer.甲状腺癌中的信号通路
Vitam Horm. 2018;106:501-515. doi: 10.1016/bs.vh.2017.05.002. Epub 2017 Jun 19.
9
Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells.靶向COPZ1非癌基因成瘾可抵消甲状腺肿瘤细胞的生存能力。
Cancer Lett. 2017 Dec 1;410:201-211. doi: 10.1016/j.canlet.2017.09.024. Epub 2017 Sep 23.
10
Inhibitor of apoptosis protein Livin promotes tumor progression and chemoradioresistance in human anaplastic thyroid cancer.凋亡抑制蛋白Livin促进人间变性甲状腺癌的肿瘤进展和放化疗抵抗。
Oncol Rep. 2021 Apr;45(4). doi: 10.3892/or.2021.7969. Epub 2021 Mar 2.
本文引用的文献
1
Immune Checkpoint Inhibitors in Cancer Therapy.癌症治疗中的免疫检查点抑制剂。
Curr Oncol. 2022 Apr 24;29(5):3044-3060. doi: 10.3390/curroncol29050247.
2
Genetic and Epigenetic Alterations Induced by Pesticide Exposure: Integrated Analysis of Gene Expression, microRNA Expression, and DNA Methylation Datasets.农药暴露诱导的遗传和表观遗传改变：基因表达、微小RNA表达和DNA甲基化数据集的综合分析
Int J Environ Res Public Health. 2021 Aug 17;18(16):8697. doi: 10.3390/ijerph18168697.
3
Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy.乳腺癌中X连锁凋亡抑制蛋白（XIAP）的表达与较短生存期及化疗耐药相关。
Cancers (Basel). 2021 Jun 4;13(11):2807. doi: 10.3390/cancers13112807.
4
A Ferroptosis-Related Signature Robustly Predicts Clinical Outcomes and Associates With Immune Microenvironment for Thyroid Cancer.一种与铁死亡相关的特征可有力预测甲状腺癌的临床结局并与免疫微环境相关联。
Front Med (Lausanne). 2021 Apr 13;8:637743. doi: 10.3389/fmed.2021.637743. eCollection 2021.
5
Prognostic implications of the BRAF-V600 mutation in papillary thyroid carcinoma based on a new cut-off age stratification.基于新的年龄分层标准的BRAF-V600突变在甲状腺乳头状癌中的预后意义
Oncol Lett. 2020 Jan;19(1):631-640. doi: 10.3892/ol.2019.11132. Epub 2019 Nov 21.
Zotero 插件